Atopic Dermatitis Market to Surge at a Robust pace by 2023
MRFR has published research on “Atopic Dermatitis Drugs Market 2023” and has also published on market overview, market share
Market Analysis :
Eczema can be a
result of pharmacologic factors, genetic, immunological or complex interplay of
the environment. Every form of eczema causes redness and itching but atopic
dermatitis is the most severe. AD may misguide the immune system resulting in
chronic diseases later on. It has different patterns resting on the patients’
age.
The global atopic
dermatitis market is projected to grow substantially at a promising 8.2% CAGR
over the predicted years (2017-2023). Atopic dermatitis (AD) or eczema as it is
popularly known as is a chronic disease that is inflammatory and is
characterized by rashes and itchy skin lesions. Generally, every age group can
get affected by this skin disease but it is more common in case of children and
infants. Rising prevalence of skin irritants mainly cosmetics, perfumes,
detergents, soaps and water can produce inflammation.
This can occur on the sides
of the neck, inside the elbows, knees, ankles, wrists and hands along with
having a tendency of developing papules that results in rashes.There are many
factors that is driving the growth of the atopic dermatitis market.Some of
these factors as per the Market Research Future (MRFR) report include
increasing prevalence of atopic dermatitis, rising prevalence of food
allergies, favorable reimbursement policies, higher treatment compliance,
higher unmet needs, promising pipeline molecule, increasing access for
treatment medication in developing countries, support from the government for
research and development,rising funding and advancing technology. On the
contrary, factors such as poor reimbursement policies and side effects from
drugs may hinder the growth of the
Atopic Dermatitis Market.
Competitive Analysis:
The global Atopic Dermatitis Market Report is fragmented and highly competitive and based on clinical
outcomes of products and new product launches. The key players are using
different strategies namely acquisitions, partnerships, joint ventures,
agreements, high expense on R&D, market initiatives, clinical trials and
new product launches to boost up their footprint in the atopic dermatitis
market.
Key Players:
Allergan Plc. (Republic of Ireland), Galderma S.A.
(Switzerland), Pfizer Inc. (U.S.), Meda Pharmaceuticals (U.S.), Bristol-Myers
Squibb (U.S.), Novartis International AG (Switzerland), Anacor Pharmaceuticals
Inc. (U.S.), Valeant Pharmaceuticals International, Inc (Canada), Regeneron
Pharmaceuticals, Inc. (U.S.), Sanofi S.A. (France), Astellas Pharma Inc.
(Japan)
Market Segmentation
·
Market
Research Future report offers an all-inclusive segmental analysis of the atopic dermatitis market on the basis of types,
application and end-user.
·
Based
on type, it is segmented into calcitonin, interferon, monoclonal antibodies,
erythropoietin, hormone and others.
·
Based
on application, the atopic dermatitis market is
segmented into infectious diseases, chronic diseases, blood disorders, cancer
and others.
·
Based on end-users, it is segmented into research centers,
clinics and hospitals.
Regional Analysis:
Based
on region, the atopic dermatitis market covers
growth opportunities and latest trends across North America, Europe, Asia
Pacific and Middle East and Africa. Of these, North America will remain the
luminary in the atopic dermatitis market. The
factors that are driving the market include high healthcare investment, government
funding in research and development, increasing use of skin irritants
especially cosmetics and perfumes and inflating patient pool. North America is
followed by Europe that holds the second largest share. Germany and France have
increased their expenditure on healthcare that ensures considerable market
growth here. The atopic dermatitis market in the Asia Pacific region is
expected to grow at the fastest pace with countries such as South Korea, China
and India heavily investing in the healthcare domain. South Korea and India are
generating substantial demand. On the other hand, the atopic dermatitis market
in Middle East and Africa will have a minimal share owing to ignorance, poor
treatment facilities and lack of disease screening.
Access Full Report Details and TOC Extensively @ https://www.marketresearchfuture.com/reports/atopic-dermatitis-market-1610
Comments
Post a Comment